Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles is a dataset published in Journal of Extracellular Vesicles (2021). On theSindex it has a DataRank of 3.7, placing it in the top 6.1% of the data-sharing corpus. It has been cited 355 times, with 100 citing works in its 1-hop citation network.
Ranks in the top 6% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.881
From this paper's citation signal
Citation Network Contribution
2.8
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Michael J. Fox Foundation for Parkinson's Research
Grant: 00900821
Biotechnology and Biological Sciences Research Council
Grant: BB/N016300/1
NIDDK NIH HHS
Grant: R01 DK125856
Cancer Research UK
Grant: 28123
NHLBI NIH HHS
Grant: R01 HL148786
NIH HHS
Grant: AI144997
Biotechnology and Biological Sciences Research Council
Grant: BB/K017462/1
NIH HHS
Grant: CA241694
NIDA NIH HHS
Grant: R01 DA047807
NHLBI NIH HHS
Grant: R01 HL140469
NCI NIH HHS
Grant: UG3 CA241694
NIMH NIH HHS
Grant: R33 MH118164
Cancer Research UK
Grant: C19591/A19076
NCI NIH HHS
Grant: R01 CA234557
NIH HHS
Grant: DA047807
NIH HHS
Grant: MH118164
NIAID NIH HHS
Grant: R01 AI144997
NIMH NIH HHS
Grant: R21 MH118164
Biotechnology and Biological Sciences Research Council
Grant: BB/R004862/1
NCI NIH HHS
Grant: R01 CA218526
NCI NIH HHS
Grant: UH3 CA241694
Irish Research Council
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01CA234557-05
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis
European Commission
Grant: 739593
Establishing the Hungarian Center of Excellence for Molecular Medicine in partnership with EMBL
European Commission
Grant: 722148
Training in Extracellular Vesicles: for benefit in Health and Disease
National Institutes of Health
Grant: 5R01DA047807-04
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use
National Institutes of Health
Grant: 1R21MH118164-01
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
National Institutes of Health
Grant: 1R01HL148786-01
AAV-Exosomes: Escaping Neutralizing Antibody and Enhancing Delivery
National Institutes of Health
Grant: 1UG3CA241694-01
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates
National Institutes of Health
Grant: 5R01CA218526-04
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
National Institutes of Health
Grant: 5R01DK125856-03
Circulating Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes
European Commission
Grant: 814495
EVPRO - Development of Extracellular Vesicles loaded hydrogel coatings with immunomodulatory activity for Promoted Regenerative Osseointegration of revision endoprosthesis
National Institutes of Health
Grant: 5R01HL140469-04
Dysregulated Adenosine Methylation of mRNA as a Novel Mechanism of Heart Failure
National Institutes of Health
Grant: 5R01AI144997-05
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
FWCI
19.32
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?
Additional file 2 of Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?
Additional file 1 of Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?
Additional file 1 of Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?
Additional file 1 of Proteomics profiling identifies extracellular vesicles’ cargo associated with tumour cell induced platelet aggregation
Additional file 1 of Proteomics profiling identifies extracellular vesicles’ cargo associated with tumour cell induced platelet aggregation
Additional file 1 of Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells
Additional file 1 of Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells
Additional file 2 of Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells
Additional file 2 of Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells
Additional file 1 of Extracellular vesicles derived from human ESC–MSCs target macrophage and promote anti-inflammation process, angiogenesis, and functional recovery in ACS-induced severe skeletal muscle injury
Additional file 1 of Extracellular vesicles derived from human ESC–MSCs target macrophage and promote anti-inflammation process, angiogenesis, and functional recovery in ACS-induced severe skeletal muscle injury
Additional file 2 of Extracellular vesicles derived from human ESC–MSCs target macrophage and promote anti-inflammation process, angiogenesis, and functional recovery in ACS-induced severe skeletal muscle injury
Additional file 2 of Extracellular vesicles derived from human ESC–MSCs target macrophage and promote anti-inflammation process, angiogenesis, and functional recovery in ACS-induced severe skeletal muscle injury
Additional file 3 of SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway
Additional file 3 of SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway
Additional file 4 of SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway
Additional file 4 of SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway
Additional file 5 of SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway
Additional file 5 of SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway